Fundraising FoxAmunix Pharmaceuticals
South San Francisco, US · 18 known investors
Find your way into Amunix Pharmaceuticals
Sign up to see every warm intro you have to Amunix Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amunix Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biopharmaceutical company discovering and developing novel biologics, protein, and peptide therapeutics.
Founders & leadership
Investors · 18
How we know: Bain Capital Life Sciences's portfolio page · baincapital.com · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: Longitude Capital's portfolio page · fiercebiotech.com · the VCSheet dataset · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
How we know: baincapital.com · Not right? Tell us
How we know: baincapital.com · Not right? Tell us
How we know: a partner's Signal profile · baincapital.com · Not right? Tell us
How we know: board seat on SEC Form D · fiercebiotech.com · Not right? Tell us
How we know: fiercebiotech.com · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements$200.6M disclosed across 2 of 6 rounds · 2020–2021
- Undisclosed amountSeries BMar 2021
Viking Global Investors (lead), ArrowMark Partners, Avidity Partners, Bain Capital Life Sciences, BlackRock, CaaS Capital Management, Casdin Capital, Clough Capital Partners, Franklin Templeton, Frazier Healthcare Partners, Janus Henderson Investors, Longitude Capital, Omega Funds, Polaris Partners, Redmile Group, Venrock
Source ↗ - Undisclosed amountseries AMar 2020
Omega Funds (lead), Longitude Capital, Polaris Partners, Redmile
Source ↗
▶$117MraisedMar 2021 · 28 investors · BiotechnologyRule 506(b)
- Angie YouExecutive Officer, Director
- Trisha MillicanDirector
- James TopperDirector
- Otello StampacchiaDirector
- David HirschDirector
- Richard HeymanDirector
- James BrushDirector
- Volker SchellenbergerExecutive Officer
- Offering amount
- $117M
- Amount sold
- $117M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$743.3KofferedJan 2021 · 1 investors · BiotechnologyRule 506(b)
- Trisha MillicanDirector
- James TopperDirector
- Otello StampacchiaDirector
- David HirschDirector
- Volker SchellenbergerExecutive Officer
- James BrushDirector
- Richard HeymanDirector
- Angie YouExecutive Officer, Director
- Offering amount
- $743.3K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.6MofferedJul 2020 · 3 investors · BiotechnologyRule 506(b)
- David HirschDirector
- Richard HeymanDirector
- Otello StampacchiaDirector
- Volker SchellenbergerExecutive Officer
- Angie YouExecutive Officer, Director
- James BrushDirector
- James TopperDirector
- Offering amount
- $2.6M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$83.6MraisedMar 2020 · 21 investors · BiotechnologyRule 506(b)
- Richard HeymanDirector
- Angie YouExecutive Officer, Director
- James BrushDirector
- James TopperDirector
- David HirschDirector
- Otello StampacchiaDirector
- Volker SchellenbergerExecutive Officer
- Offering amount
- $83.6M
- Amount sold
- $83.6M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Amunix Pharmaceuticals went on to found or lead other companies.
In the news
Frequently asked questions
- What does Amunix Pharmaceuticals do?
- Biopharmaceutical company discovering and developing novel biologics, protein, and peptide therapeutics.
- Who are Amunix Pharmaceuticals's investors?
- Amunix Pharmaceuticals's investors include Bain Capital Life Sciences, Frazier Life Sciences, Longitude Capital, Viking Global, BlackRock, Casdin Capital, Franklin Templeton, Frazier Healthcare Partners and 5 more.
- How much funding has Amunix Pharmaceuticals raised?
- Amunix Pharmaceuticals has disclosed $200.6M raised across 2 of its 6 known rounds.
- Where is Amunix Pharmaceuticals headquartered?
- Amunix Pharmaceuticals is headquartered in South San Francisco, US.